OCM
GILD icon

Osbon Capital Management’s Gilead Sciences GILD Stock Holding History

Osbon Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5K Hold
90
– – 0.01% 267
2025
Q4 		$11K Buy
+90
New +$10.9K 0.01% 220

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Osbon Capital Management's GILD Position: Q1 2026 in Review

Osbon Capital Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 90 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #267.

Osbon Capital Management first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Osbon Capital Management held 90 shares of Gilead Sciences worth $12.5K as of Q1 2026.
  • Osbon Capital Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Osbon Capital Management's portfolio in Q1 2026, its #267 holding.
  • Osbon Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Osbon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.